Search Results - "BHASI, K"

SPLINDID: a semi-parametric, model-based method for obtaining transcription rates and gene regulation parameters from genomic and proteomic expression profiles by Bhasi, Kavitha, Forrest, Alan, Ramanathan, Murali

“…Purpose: To evaluate a semi-parametric, model-based approach for obtaining transcription rates from mRNA and protein expression. Methods: The transcription…”
Get full text

An association between autoreactive antibodies and anti-interferon-β antibodies in multiple sclerosis by Garg, N., Weinstock-Guttman, B., Bhasi, K., Locke, J., Ramanathan, M.

“…Approximately 5—25% of interferon-β (IFN-β) treated multiple sclerosis (MS) patients develop anti-IFN-β neutralizing antibodies (NAb) but the patient-specific…”
Get full text

Characterization of snake skin by thermoanalytical techniques by BHASI, K, RIGA, A. T, ALEXANDER, K. S

Get full text

MIMICz-An Audio Corpus for the Competency Evaluation of Voice Mimicking by C, Bhasi K., Rajan, Rajeev

“…The paper introduces a data corpus for voice mimicry analysis. The dataset comprises mimicry samples of 25 celebrities. Samples are recorded with professional…”
Get full text

Pharmacogenetics of MXA SNPs in interferon-β treated multiple sclerosis patients by Weinstock-Guttman, Bianca, Tamaño-Blanco, Miriam, Bhasi, Kavitha, Zivadinov, Robert, Ramanathan, Murali

“…Abstract The myxovirus resistance A ( MXA ) mRNA has been extensively investigated for assessing the biologic responses of multiple sclerosis (MS) patients to…”
Get full text

Genomic effects of once-weekly, intramuscular interferon- beta 1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients by Weinstock-Guttman, B, Bhasi, K, Badgett, D, Tamano-Blanco, M, Minhas, M, Feichter, J, Patrick, K, Munschauer, F, Bakshi, R, Ramanathan, M

“…Purpose: To characterize gene expression in multiple sclerosis (MS) patients after the first dose and chronic dosing of 30 approximately equal to g, once…”
Get full text

Application of SPLINDID, a semiparametric, model-based method for pharmacogenomic modeling of mRNA dynamics by BHASI, Kavitha, FORREST, Alan, RAMANATHAN, Murali

“…This study was conducted to evaluate the applicability of SPLINDID, a semiparametric, model-based approach for obtaining transcription rates from the…”
Get full text

Analysis of pharmacokinetics, pharmacodynamics, and pharmacogenomics data sets using VizStruct, a novel multidimensional visualization technique by Bhasi, Kavitha, Zhang, Li, Zhang, Aidong, Ramanathan, Murali

“…Data visualization techniques for the pharmaceutical sciences have not been extensively investigated. The purpose of this study was to evaluate the usefulness…”
Get full text

An association between autoreactive antibodies and anti-interferon-[Beta] antibodies in multiple sclerosis by Garg, N, Weinstock-Guttman, B, Bhasi, K, Locke, J, Ramanathan, M

“…Approximately 5--25% of interferon-β (IFN-β) treated multiple sclerosis (MS) patients develop anti-IFN-β neutralizing antibodies (NAb) but the patient-specific…”
Get full text